Norges Bank’s Ascendis Pharma A/S ASND Stock Holding History

Norges Bank’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,727	Closed	-$346K	–	2093
2022 Q2	$346K	Hold	3,727	–	–	﹤0.01%	2022
2022 Q1	$437K	Sell	3,727 -35,044	-90%	-$4.06M	﹤0.01%	2110
2021 Q4	$5.22M	Buy	+38,771	New	+$5.77M	﹤0.01%	1906

Other funds holding ASND

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Norges Bank's ASND Position: Q3 2022 in Review

Norges Bank sold out of Ascendis Pharma A/S (ASND) in Q3 2022, closing a stake of 3,727 shares — an estimated $346K sold.

Norges Bank first reported a position in ASND in Q4 2021 and held it in 3 quarters. The position peaked at $5.22M in Q4 2021. 183 funds tracked by Wall St. Rank hold ASND as of Q3 2022.

Norges Bank reported no remaining Ascendis Pharma A/S position as of Q3 2022 after selling out during the quarter.
Norges Bank sold 3,727 Ascendis Pharma A/S shares in Q3 2022, an estimated $346K.
Norges Bank first reported a position in Ascendis Pharma A/S in Q4 2021 and held it in 3 quarters.
Norges Bank's Ascendis Pharma A/S position peaked at $5.22M in Q4 2021.
183 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.